Recommendations to Improve Adverse Event Reporting in Clinical Trial Publications: A Joint Pharmaceutical Industry/Journal Editor Perspective, published in The BMJ in October 2016, provides guidance on clinically relevant and more informative adverse event reporting to improve patient care and increase the credibility of industry-sponsored publications.
Please join us for a presentation by an MPIP member who helped draft these recommendations and learn how to take practical steps to implement them in your publications.
At the end of this session, participants should be able to:
- Identify best practice recommendations for adverse event (AE) reporting in clinical trial publications
- Implement these recommendations for manuscripts currently in development as well as for future submissions
- Understand and appreciate why MPIP published these best practice recommendations for AE reporting